Compositional formulations are provided that comprise at least one tocotrienol or a derivative thereof, in combination with compounds derived from plant extracts. The compositions can be provided in a functionally acceptable carrier, or separately in a combined regimen. In some examples, the compositions can be effective for reducing, preventing or treating medical conditions including, for example, benign tissue growths, pre-cancerous lesions, cancer, inflammations, viral infections, bacterial infections, fungal infections, parasitic infections, impaired bodily function, or cell and tissue damage due to trauma, cell and/or tissue injury from stroke events, cell and/or tissue damage from ischemic events. The mechanism of action for cancer prevention and therapy includes telomerase and/or angiogenesis inhibiton.本發明提供了組合製劑,其包含至少一種生育三烯酚或其衍生物與得自植物提取物的化合物的組合。所述組合物可在機能可接受的載體中提供,或者在聯合用藥中單獨地提供。在一些例子中,所述組合物可以有效降低、預防或治療醫學不良狀態,所述醫學不良狀態包括例如良性組織生長、癌前期病變、癌症、炎症、病毒感染、細菌感染、真菌感染、寄生物感染、軀體功能受損、或者由於創傷引起的細胞和組織損害、源於中風事件的細胞和/或組織損傷、源於局部缺血事件的細胞和/或組織損害。癌症預防和治療的作用機理包括端粒酶和/或血管新生抑制。
